Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:40 PM
Ignite Modification Date:
2025-12-24 @ 11:40 PM
NCT ID:
NCT00031551
Eligibility Criteria:
* INCLUSION CRITERIA:
1. Male or female oncology patients who are enrolled in participating stomatogenic autologous or allogeneic PBSCT/BMT protocols, and are willing to participate in this study concurrently
2. Able to understand and sign protocol consent or assent
3. Age 16 years or older
EXCLUSION CRITERIA:
1. Pregnant or lactating females
2. Unable to follow oral rinsing directions
3. Intubation
4. Chronic use of medications confounding assessment of the inflammatory response (non-steroidal antiinflammatory drugs, antihistamines, and steroids- with the exception of decadron that is commonly used as an antiemetic in the PBSCT/BMT setting)
5. Pre-existing oral infection or upper respiratory infection that might maximize the possibility of an infection or sepsis contributing to a drug-related adverse event
6. Known hypersensitivity or allergic reaction to etanercept
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
16 Years
Study:
NCT00031551
Study Brief:
Protocol Section:
NCT00031551